Identify opportunities to improve care
With access to everyday utilization, cost and performance data right at your fingertips, our hospice analytics tools identify opportunities to improve patient care and lower costs. Decision support tools built specifically for hospice pharmacy include:
- Hospice Best Practice Indicators (HBPIs)
- High Quality Network
- PEPPER opportunity
- High dollar report
- Identify deprescribing opportunities
By utilizing these analytics tools, along with the support of our account management and clinical team, we can partner to meet your drug utilizations goals.
Analytics tools we offer
HospiTrac™ for utilization, cost and performance
Get the insights you need with a user-friendly, web-based tool. The HospiTrac™ reporting suite does the work for you, translating mountains of utilization, cost and performance data into concise, meaningful and valuable information for clinical and administrative managers.
HospiRxMonitor™ for prescriptions and profiles
Streamline reporting by using analytics with prescription and profiled data. HospiRxMonitor is a comprehensive reporting solution that uses scenario-based logic to look at compliance, patient outcomes, quality assurance process improvement and benchmarking.
HospiSurveillance for EMR data
By using the electronic medical records (EMR) interface and data in a new way, our clinical staff can connect with the hospice without changing its existing pharmacy services program. This proactive approach helps you make better decisions.
The support our hospice staff gets from Optum is priceless, and the ability to utilize the on-call pharmacist has proven to be crucial.
Hospice Director
Jennifer L.
Related healthcare insights
Article
Learn how to build a holistic engagement strategy to help improve member satisfaction and better achieve your goals.
Case study
See how a large health system improved care coordination and patient experience with Change Healthcare Stratus Imaging Share.
Article
From GLP-1s to oncology, learn which new and upcoming drugs could become additional sources of pharmacy spending.